Synthesis of novel pleuromutilin derivatives. Most of compounds possessed potent in vitro antibacterial activity against MRSA. Compound 11c exhibited superior in vivo efficacy to that of tiamulin against MRSA at the dose of 40 mg/kg in the mouse systemic infection model.